Beyond reverse pharmacology: Mechanism-based screening of Ayurvedic drugs

Journal of Ayurveda and Integrative Medicine

Volumn 1, Issue 4, 2010, Pages 257-265

  Lele, R ^a  

^a LILAVATI HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Ayurveda; Reverse Pharmacology

Indexed keywords

ALPINIA GALANGA EXTRACT; ANTIOXIDANT; AYURVEDIC DRUG; BAICALEIN; CURCUMIN; DIURETIC AGENT; FORSKOLIN; GINGER EXTRACT; GUDUCHI; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; MEDHYA RASAYANA; METFORMIN; PLACEBO; PUNARNAVA; RASAYANA; RESERPINE; TERMINALIA ARJUNA EXTRACT; TROLOX C; TYLOPHORA EXTRACT; UNCLASSIFIED DRUG; VITAMIN D;

ALPINIA GALANGA; ANTIOXIDANT ACTIVITY; AYURVEDA; BARK; BIOMEDICINE; COLON CANCER; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG COST; DRUG MEGADOSE; DRUG SCREENING; ELECTRON TRANSPORT; HEART PROTECTION; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IN VITRO STUDY; INDIA; INFECTION; MEDICINAL PLANT; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OSTEOARTHRITIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SINGLE DRUG DOSE; SYNOVIOCYTE; TERMINALIA ARJUNA; TYLOPHORA;

EID: 79952952177     PISSN: 09759476     EISSN: 09762809     Source Type: Journal    
DOI: 10.4103/0975-9476.74435     Document Type: Review

References (38)

1. Vakil RJ. A clinical trial of Rauwolfia serpentina in essential hypertension. Br Heart J 1949;11:350-5.
2. Tilak JC, Devasagayam TP, Adhikari S, Lele RD, Kon T, Handa O, et al. Cellular Membrane Protection against reactive oxygen species by Terminalia Arjuna and its active component Baicalein. J Clin Biochem Nutr 2006;39:75-87. (Pubitemid 44433559)
3. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free Radicals and antioxidants in Human Health: Current Status and future Prospects. J Assoc Physicians India 2004;52:794-804. (Pubitemid 41279997)
4. Gupta R, Singhal S, Goyal A, Sharma VN, Anti-oxidant and hypocholesterolemic effects of terminalia Arjuna bark powder: A randomized placebo-controlled trial. J Assoc Physicians India 2001;49:231-5. Lele: Beyond reverse pharmacology
5. Kohli K, Ansari AV, Raheman MJ. Curcumin, a natural antiinflammatory agent. Indian J Pharmacol 2005;37:141-7.
6. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 1998 Nov 5;396(6706):77-80 (Pubitemid 28520452)
7. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, et al. Curcumin is an invivo inhibitor of angiogenesis. Mol Med 1998;4:376-83.
8. Agarwal SS, Singh VK. Immunomodulators: A review of studies on Indian medicinal plants and synthetic peptides. PINSA 1999;365:179-204.
9. Tak PP, Firestein GS. NF-kB: A key role in inflammatory disease. J Clin Invest 2001;107:7-11. (Pubitemid 32047405)
10. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-42. (Pubitemid 32096826)
11. Sainis KB, Goel A, Chintalwar GJ, Sipahimalani AT, Banerji A. Immunomodulatory properties of stem extracts of Tinospora cordifolia: Cell target and active principles. In: Upadhya SN, editor. Immunomodulation. New Delhi, India: Narosa Publishing House; 1997.
12. Raghu R, Sharma D, Ramakrishnan R, Khanam S, Chintalwar GJ, Sainis KB. Molecular events in the activation of B cells and macrophages by a non-microbial TLR-4 agonist G14A from Tinospora cordifolia. Immunol Lett 2009;123:60-71.
13. Desai VR, Ramakrishnan R, Chintalwar GJ, Sainis KB. G1-4A an immunomodulatory polysaccharide From Tinospora cordifolia, modulates macrophages response and protects mice against LPS- induced endotoxin shock. Int Immunopharmacol 2007;7:1375-86. (Pubitemid 47126377)
14. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskelal disorders. Med Hypotheses 1992;39:342-8. (Pubitemid 23010771)
15. Thatte UM, Rege NN, Phatak SD, Dahanukar SA. The flip side of Ayurveda. J Postgrad Med 1993;39:179-82,182a.
16. Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt HH, et al. A randomized placebo controlled crossover study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 2000;8:9-12. (Pubitemid 30032721)
17. Zhu M, Rajamani S, Kaylor J, Han S, Zhou F, Fink AL. The flavonoid Baicalein inhibits fibrillation of a synuclein and disaggregates existing fibrils. J Biol Chem 2004;279: 26846-57. (Pubitemid 38812518)
18. Li BQ, Fu T, Gong WH, Dunlop N, Kung H, Yan Y, et al. The flavonoid baicalein exhibits anti-inflammatory activity by binding to chemokines. Immunopharmacology 2000;49:295-306.
19. Mungantiwar AA, Nair AM, Shinde UA, Dikshit VJ, Saraf MN, Thakur VS, et al. Studies on the immunomodulatory effects of Boerhavia diffuse alkaloid fraction. J Ethnophamacol 1999;65:125-31. (Pubitemid 29267958)
20. Rao TS, Basu N. Siddiqui HH anti-inflammatory activity of Curcumin analogus. Indian J Med Res 1982;75:574-8. (Pubitemid 13226183)
21. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK. Antiinflammatory and irritant activities of curcumin analogues in rats. Agents Actions 1982;12:508-15. (Pubitemid 13218984)
22. Ali M, Bagati A, Gupta J. Synthesis and anti-inflammatory activity of Curcumin analogs. Indian Drugs 1995;32:562-05.
23. Itokawa H, Hirayama F, Funakoshi K, Takeya K. Studies in the antitumor bisabolane Sesquiterpenoids isolated from Curcuma Xanthorohiza. Chem Pharm Bull 1985;33:3488-92. (Pubitemid 16222840)
24. Nagabhushan M. Bhide V Curcumin as an inhibitor of cancer. J Amer Coll Nutr 1992;11:192-8.
25. Kim JM, Araki S, Kim DJ, Park CB, Takasuka N, Baba- Toriyama H, et al. Chemoprevention effects of carotinoids and Curcumin on mouse colon carcinogenesis after 1, 2 dimethyl hydrazine initiation. Carcinogenesis 1998;19:81-5. (Pubitemid 28376829)
26. Chun KS, Sohn Y, Kim HS, Kim OH, Park KK, Lee JM, et al. Anti-tumour potential of naturally occurring diarylheptanoids structurall, related to curcumin. Mutat Res 1999;428:49-57. (Pubitemid 29389676)
27. Johnson JJ, Mukhtar H. Curcumin for Chemoprevention of colon Ca. Cancer Lett 2007;255:170-81.
28. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Antitumour and oxidant activity of natural Circuminoids. Cancer Latt 1995;94:79-83.
29. Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH, et al. Induction of Apoptosis through generation of ROS, downregulation of Bcl-XL and IAP release of cytochronic, inhibition of Akt. Carcinogenesis 2003;24:1199-208.
30. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential of curcumin in human prostate cancer: III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 2001;47:293-303. (Pubitemid 32521749)
31. Aggarwal BB, Kumar A, Bhartic AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003;23:363-98. (Pubitemid 36361976)
32. Len TH, Mad MC. The molecular mechanisms for antitumerigenic effects of curcumin. Curr Med Chem Anticancer Agents 2002;2:357-70.
33. Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A. Suppression of NF- kappa B activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol 2007;73:1434-45. (Pubitemid 46452591)
34. Cadler PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002;61:345-58.
35. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, et al. Influence of Vit. D deficiency and Vit. D receptor polymorphism on Tuberculosis among Gujarathi Asian Indians in west London: A case control study. Lancet 2000;355:618-21.
36. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768-80.
37. Roche HM. Two-way interaction between nutrition and the human genome. Biochem Soc Trans 2004;32:993-1002.
38. Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: Can Ayurveda show the way forward? Drug Discov Today 2009;14:804-11.